Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $20.49, but opened at $20.06. Ascentage Pharma Group International shares last traded at $19.91, with a volume of 5,660 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. started coverage on shares of Ascentage Pharma Group International in a report on Thursday, March 27th. They issued an “overweight” rating on the stock.
Read Our Latest Report on AAPG
Ascentage Pharma Group International Stock Down 2.7 %
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Recommended Stories
- Five stocks we like better than Ascentage Pharma Group International
- Should You Invest in Penny Stocks?
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- 3 Dividend Kings To Consider
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- Options Trading – Understanding Strike Price
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
